What Are Medpace Holdings Inc.'s Key Financial Figures?
| Fiscal year | FY2025 ended December 31, 2025 | FY2024 ended December 31, 2024 | FY2023 ended December 31, 2023 | FY2022 ended December 31, 2022 |
|---|---|---|---|---|
| Revenue | $2.5 billion | $2.1 billion | $1.9 billion | $1.5 billion |
| Operating income | $535 million | $447 million | $337 million | $279 million |
| Operating margin | 21.1% | 21.2% | 17.9% | 19.1% |
| Net income | $451 million | $404 million | $283 million | $245 million |
| Net margin | 17.8% | 19.2% | 15.0% | 16.8% |
| Operating cash flow | $713 million | $609 million | $433 million | $388 million |
| Capital expenditures | $31 million | $37 million | $37 million | $37 million |
| Free cash flow | $682 million | $572 million | $397 million | $351 million |
Operating margin held roughly steady between fiscal 2024 and 2025, which separates pricing and cost discipline from revenue growth alone. Free cash flow (operating cash flow minus capital expenditures) was $682 million against net income of $451 million; cash generation covered reported earnings.
What Does Medpace Holdings Inc.'s Balance Sheet Show?
| Cash and cash equivalents | $497 million |
|---|---|
| Long-term debt | Not reported |
| Total assets | $2.0 billion |
| Total liabilities | $1.5 billion |
| Shareholders' equity | $459 million |
| Current ratio | 0.7x |
Balance sheet values are as of the end of fiscal 2025. Income statement figures describe a whole year; balance sheet figures describe a single day, so the two answer different questions.
Where These Numbers Come From
Every figure on this page is a value Medpace Holdings Inc. reported in its own SEC filings, read from the SEC's XBRL data (accession 0001668397-26-000006 for fiscal year 2025). Ratios are computed from those reported values. Figures were retrieved on October 7, 2026; a later amendment or a new annual report can change them, and the filing itself always takes precedence over this summary.
Each fiscal year is labeled by the calendar year in which it ended, so a company that names the same period differently in its own filings (many retailers whose year ends in January) may use another label. A year is left out of the table when the SEC data set holds no value for it. A figure shown as "Not reported" means the company did not file a value under the standard tag Swoopr reads, not that the amount was zero. This page is educational and describes reported history only; it is not a forecast or a recommendation.
Frequently Asked Questions
What was Medpace Holdings Inc.'s revenue in fiscal 2025?
Medpace Holdings Inc. reported revenue of $2.5 billion for the fiscal year ended December 31, 2025, according to its SEC filings.
What is Medpace Holdings Inc.'s operating margin?
Medpace Holdings Inc.'s operating margin was 21.1% in fiscal 2025: operating income of $535 million on revenue of $2.5 billion.
How much free cash flow did Medpace Holdings Inc. generate?
Operating cash flow of $713 million less capital expenditures of $31 million gives free cash flow of $682 million for fiscal 2025.